AeroVironment AVAV 深 沪
等待开盘 10-18 09:30:00 美东时间
350.59
-23.510
-6.28%
华盛通- 最 高368.73
- 今 开364.50
- 成交量 161.65万股
- 最 低 349.09
- 昨 收 374.10
- 总市值 175.06亿
- 52周最高 417.86
- 市盈率 静 226.45
- 换手率 3.24%
- 52周最低 102.25
- 委 比 47.78%
- 总股本 4993.22万
- 历史最高 417.86
- 量 比 1.48
- 振 幅 5.25%
- 历史最低 16.98
- 每 手 1
- 风险率 31.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Defense stocks slide after U.S. Treasury signals possible limits on buybacks
Shares of major U.S. defense contractors fell on Wednesday following remarks from Treasury Secretary Scott Bessent, who said the government may ask defense companies to scale back share repurchases am...
10-16 01:23
AeroVironment Introduces New All-electric The Vapor Compact Long Endurance Unmanned Aircraft System
https://www.avinc.com/resources/press-releases/view/av-launches-next-generation-vapor-cle-compact-long-endurance-helicopter-uas
10-13 21:13
Symbotic, Serve Robotics, AeroVironment, aTyr Pharma, Cummins: Insider Moves Unveiled
Insiders have been trading these 5 stocks: (($SYM)), (($SERV)), (($AVAV)), (($A...
10-11 21:00
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
Canaccord Genuity Maintains Buy on AeroVironment, Raises Price Target to $430
Canaccord Genuity analyst Austin Moeller maintains AeroVironment (NASDAQ:AVAV) with a Buy and raises the price target from $305 to $430.
10-07 22:59
How Is The Market Feeling About AeroVironment Inc?
AeroVironment Inc's (NYSE:AVAV) short interest as a percent of float has risen ...
10-07 04:00
Mercury Systems and Nightwing collaborate to enhance cybersecurity
Mercury Systems (NASDAQ:MRCY) on Monday announced an agreement to enhance the cyber resiliency of Mercury Systems hardware with Nightwing cyber resiliency technology. Through this agreement, the compa...
10-06 19:24
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
美股大行评级 | 潜在涨幅216.96%！Kazia Therapeutics获Maxim Group升目标价至20美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Kazia Therapeutics"买入"评级，目标价从15美元升至20美元；Baird：维持Taysha Gene Therapies"跑赢大市"评级，目标价从7美元升至12美元
10-03 14:32
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
